METTL3 and Reduced sperm motility: Collectively, the upregulated expression of METTL3 triggers the occurrence and progression of asthenozoospermia, RIF, and infertility, indicating that a high level of METTL3 may serve as a risk indicator for these diseases as well as a potential diagnostic biomarker and therapeutic target in clinical settings.